The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis
Tobias Puengel(Charité - Universitätsmedizin Berlin), Frank Tacke(Charité - Universitätsmedizin Berlin), Christian Trautwein(TUM Klinikum), Philippe Clément-Lacroix(Galapagos (France)), Nurdan Güldiken(Universität Ulm), Pavel Strnad(RWTH Aachen University), Laurent Sanière(Galapagos (France)), Kenji F. Shoji(Galapagos (France)), Marlene Kohlhepp(Charité - Universitätsmedizin Berlin), Reginald Brys(Galapagos (Belgium)), Jana Hundertmark(Charité - Universitätsmedizin Berlin), Philippe Pujuguet(Galapagos (France)), Steve De Vos(Galapagos (France)), Tom Luedde(Düsseldorf University Hospital), Marielle Auberval(Galapagos (France)), Florence Marsais(Galapagos (France))
Cited by 83
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k